BioVie Inc. Email Format

Biotechnology ResearchNevada, United States11-50 Employees

BioVie Inc. is a clinical-stage biotechnology company based in Carson City, Nevada, focused on neurological and liver diseases. Its neurology program centers on the convergence of biochemistry, cellular energetics, and neuroprotection to explore molecules that may reduce inflammation, enhance energy transfer in the central nervous system, and support neuronal health, with NE3107 as the lead candidate studied in humans for Alzheimer's and Parkinson's disease. The company is also pursuing therapies for cirrhosis-related ascites, testing approaches to improve patient comfort, reduce the need for procedures, and extend time outside the hospital using a continuous infusion of terlipressin delivered via a wearable pump.

The company targets patients with neurodegenerative diseases and advanced liver disease, along with clinicians involved in their care. A recent development highlighted in 2026 notes progress on BIV-201, a continuous-infusion formulation of terlipressin for liver disease that has received FDA Orphan and Fast Track designations.

Get verified BioVie Inc. emails free

Company overview Employee directory